share_log

Hainan Haiyao (SZSE:000566) Is Making Moderate Use Of Debt

Hainan Haiyao (SZSE:000566) Is Making Moderate Use Of Debt

海南海藥(深交所代碼:000566)正在適度使用債務
Simply Wall St ·  2023/08/23 18:33

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved when a business collapses. As with many other companies Hainan Haiyao Co., Ltd. (SZSE:000566) makes use of debt. But should shareholders be worried about its use of debt?

傳奇基金經理Li·Lu曾說過,最大的投資風險不是價格的波動,而是你是否會遭受永久性的資本損失。當你考察一家公司的風險有多大時,考慮它的資產負債表是很自然的,因為當一家企業倒閉時,債務往往會涉及到它。與許多其他公司一樣海南海藥股份有限公司(SZSE:000566)利用債務。但股東是否應該擔心它的債務使用情況?

When Is Debt A Problem?

什麼時候債務是個問題?

Generally speaking, debt only becomes a real problem when a company can't easily pay it off, either by raising capital or with its own cash flow. In the worst case scenario, a company can go bankrupt if it cannot pay its creditors. However, a more usual (but still expensive) situation is where a company must dilute shareholders at a cheap share price simply to get debt under control. By replacing dilution, though, debt can be an extremely good tool for businesses that need capital to invest in growth at high rates of return. When we think about a company's use of debt, we first look at cash and debt together.

一般來說,只有當一家公司無法輕鬆償還債務時,債務才會成為一個真正的問題,無論是通過籌集資金還是用自己的現金流。在最糟糕的情況下,如果一家公司無法償還債權人的債務,它可能會破產。然而,一種更常見(但仍然昂貴)的情況是,一家公司必須以低廉的股價稀釋股東的股份,才能控制債務。然而,通過取代稀釋,對於需要資本投資於高回報率增長的企業來說,債務可以成為一個非常好的工具。當我們考慮一家公司的債務用途時,我們首先會把現金和債務放在一起看。

Check out our latest analysis for Hainan Haiyao

查看我們對海南海藥的最新分析

What Is Hainan Haiyao's Debt?

海南海藥的債務是什麼?

As you can see below, Hainan Haiyao had CN¥4.40b of debt, at March 2023, which is about the same as the year before. You can click the chart for greater detail. However, it also had CN¥1.18b in cash, and so its net debt is CN¥3.22b.

正如你在下面看到的,截至2023年3月,海南海藥的債務為44億元人民幣,與前一年大致相同。您可以單擊圖表查看更多詳細資訊。然而,它也有11.8億元現金,因此其淨債務為32.2億元。

debt-equity-history-analysis
SZSE:000566 Debt to Equity History August 23rd 2023
深圳證交所:000566債轉股歷史2023年8月23日

How Healthy Is Hainan Haiyao's Balance Sheet?

海南海藥的資產負債表有多健康?

We can see from the most recent balance sheet that Hainan Haiyao had liabilities of CN¥3.98b falling due within a year, and liabilities of CN¥1.37b due beyond that. On the other hand, it had cash of CN¥1.18b and CN¥1.22b worth of receivables due within a year. So it has liabilities totalling CN¥2.95b more than its cash and near-term receivables, combined.

從最近的資產負債表可以看出,海南海藥有39.8億元的負債在一年內到期,還有13.7億元的負債在一年內到期。另一方面,它有11.8億元現金和12.2億元人民幣的應收賬款在一年內到期。因此,該公司的負債總額為人民幣29.5億元,比現金和近期應收賬款加起來還要多。

While this might seem like a lot, it is not so bad since Hainan Haiyao has a market capitalization of CN¥5.83b, and so it could probably strengthen its balance sheet by raising capital if it needed to. However, it is still worthwhile taking a close look at its ability to pay off debt. There's no doubt that we learn most about debt from the balance sheet. But you can't view debt in total isolation; since Hainan Haiyao will need earnings to service that debt. So when considering debt, it's definitely worth looking at the earnings trend. Click here for an interactive snapshot.

雖然這看起來可能很多,但並不是很糟糕,因為海南海藥的市值為人民幣58.3億元,因此如果需要的話,它可能會通過籌集資本來加強其資產負債表。然而,仍值得密切關注其償債能力。毫無疑問,我們從資產負債表中瞭解到的債務最多。但你不能完全孤立地看待債務,因為海南海藥需要盈利來償還債務。因此,當考慮債務時,絕對值得關注收益趨勢。點擊此處查看互動快照。

Over 12 months, Hainan Haiyao made a loss at the EBIT level, and saw its revenue drop to CN¥1.7b, which is a fall of 17%. We would much prefer see growth.

在過去的12個月裡,海南海藥的息稅前利潤出現虧損,其收入降至人民幣17億元,降幅為17%。我們更希望看到增長。

Caveat Emptor

告誡買入者

While Hainan Haiyao's falling revenue is about as heartwarming as a wet blanket, arguably its earnings before interest and tax (EBIT) loss is even less appealing. Indeed, it lost CN¥123m at the EBIT level. Considering that alongside the liabilities mentioned above does not give us much confidence that company should be using so much debt. So we think its balance sheet is a little strained, though not beyond repair. Another cause for caution is that is bled CN¥143m in negative free cash flow over the last twelve months. So suffice it to say we do consider the stock to be risky. There's no doubt that we learn most about debt from the balance sheet. However, not all investment risk resides within the balance sheet - far from it. We've identified 2 warning signs with Hainan Haiyao (at least 1 which is concerning) , and understanding them should be part of your investment process.

雖然海南海藥收入的下降令人心碎,但可以說,它的息稅前利潤(EBIT)虧損就更沒有吸引力了。事實上,在息稅前利潤水準上,它虧損了1.23億元。考慮到除了上面提到的債務,我們對公司應該使用如此多的債務沒有太大的信心。因此,我們認為它的資產負債表有點緊張,但並不是無法修復。另一個值得警惕的原因是,在過去的12個月裡,自由現金流為負1.43億元。因此,可以說,我們確實認為這只股票是有風險的。毫無疑問,我們從資產負債表中瞭解到的債務最多。然而,並非所有投資風險都存在於資產負債表中--遠非如此。我們已經確定了兩個警告信號與海南海耀合作(至少有1個是相關的),瞭解他們應該是你投資過程的一部分。

Of course, if you're the type of investor who prefers buying stocks without the burden of debt, then don't hesitate to discover our exclusive list of net cash growth stocks, today.

當然,如果你是那種喜歡在沒有債務負擔的情況下購買股票的投資者,那麼不要猶豫,今天就來看看我們的淨現金成長型股票獨家名單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫.或者,也可以給編輯組發電子郵件,地址是暗示Wallst.com。
本文由Simply Wall St.撰寫,具有概括性.我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議.它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況.我們的目標是為您帶來由基本面數據驅動的長期重點分析.請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內.Simply Wall St.對上述任何一隻股票都沒有持倉.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論